Examples
Worked examples
- Is an instance
A five-person medical-device startup wins an NIH SBIR Phase I award to establish technical feasibility for a diagnostic device, then a Phase II award to build and validate a prototype toward FDA submission -- all funds paid directly to the company, which retains title to any resulting patents subject to standard Bayh-Dole government-use rights.
- Is an instance
A faculty inventor forms a spinout to pursue an NSF SBIR Phase I award for a lab-originated sensor technology; because SBIR requires the PI's primary employment to be with the small business, the faculty member adjusts their appointment or names a co-founder as PI, while the university's technology transfer office negotiates an exclusive license to the underlying patent.
Counter-examples
Looks similar, but isn't
- Not an instance
A university receiving an NIH R01 research grant directly, with no small-business applicant of record, is not SBIR -- even if a startup later licenses the resulting invention from the university's technology transfer office.
- Not an instance
A startup raising a seed round from a venture capital fund is not SBIR -- SBIR is non-dilutive federal award funding (grant/contract), not an equity investment.
Editorial commentary
SBIR (Small Business Innovation Research) is a U.S. federal program, established by the Small Business Innovation Development Act of 1982 (Public Law 97-219), that reserves a fixed percentage of participating agencies’ extramural R&D budgets for phased, non-dilutive awards to small, for-profit businesses developing technology with both a federal-mission need and commercial potential. "Non-dilutive" is the operational core of the definition: the awarding agency takes no equity and does not own the intellectual property the awardee develops, and funds are disbursed as a grant, cooperative agreement, or contract rather than an investment. Eleven federal agencies with extramural R&D budgets above the statutory threshold currently run SBIR programs (five of the same eleven also run the closely related STTR program); each must obligate a minimum share of that budget to SBIR awards.
Examples
- A five-person medical-device startup, with no university partnership required, wins an NIH SBIR Phase I award (branded “America’s Seed Fund” at several agencies) to establish technical feasibility for a diagnostic device, then a Phase II award to build and validate a prototype toward FDA submission — all funds paid directly to the company, with the company retaining title to any resulting patents subject to the government’s standard Bayh-Dole rights.
- A faculty inventor forms a spinout company to pursue an NSF SBIR Phase I award for a lab-originated sensor technology. Because the Principal Investigator’s primary employment must be with the small business for SBIR (unlike STTR), the faculty member reduces their university appointment or brings in a co-founder as PI, while the university’s technology transfer office negotiates an exclusive license or option agreement to the underlying patent so the startup has a defined path to market.
Not SBIR
- A university receiving an NIH R01 research grant directly, with no small-business applicant of record, is not SBIR — even if a startup later licenses the resulting invention from the university’s technology transfer office. SBIR requires the awardee of record to be the small business itself.
- A startup raising a seed round from a venture capital fund is not SBIR. SBIR is federal award funding (grant/contract), not equity investment — no ownership is exchanged and there is no federal program eligibility gate on the transaction the way there is for an SBIR award.
- An STTR award is a distinct, sibling program under the same statutory family, not SBIR itself — see the comparison below.
How the program works: three phases
SBIR funds work in stages, and only the first two are actually paid for by the SBIR set-aside:
- Phase I — feasibility. Typically six to twelve months. As of 2026, the statutory guideline cap is $323,090 (agencies may exceed this only with SBA waiver approval; several agencies, e.g. DoD’s “Phase I-Open” track, fund smaller awards in the tens of thousands).
- Phase II — full R&D and prototype development, typically up to two years. The 2026 statutory guideline cap is $2,153,927. Only businesses that completed a Phase I are normally eligible, though some agencies run Phase II-only “Direct to Phase II” tracks. The 2026 reauthorization (see below) added a new higher-value “Strategic Breakthrough” award category at select agencies with much larger caps.
- Phase III — commercialization. Not funded by the SBIR set-aside at all; it describes any follow-on work, of any dollar value or duration, that derives from a Phase I/II project and is funded from other sources — private capital, a non-SBIR federal contract, or (frequently, for university-originated technology) a license negotiated through the institution’s technology transfer office.
Eligibility requirements
To apply for an SBIR award, a business must, at minimum:
- Be organized as a U.S. for-profit entity.
- Be more than 50% owned and controlled by U.S. citizens or permanent residents (with specific exceptions for majority venture-capital, hedge-fund, or private-equity ownership at some agencies).
- Have no more than 500 employees, including affiliates, at the time of award.
- Have a Principal Investigator whose primary employment is with the small business for the duration of the award — this is the single biggest practical barrier for university-originated SBIR proposals, since a full-time tenured or tenure-track faculty appointment does not, by itself, satisfy it.
A university itself cannot be the SBIR awardee — the small business is always the prime recipient, though the business may subcontract a portion of the research back to a university lab.
SBIR vs. STTR
STTR (Small Business Technology Transfer), created a decade later by the Small Business Technology Transfer Act of 1992, exists specifically to remove the PI-employment barrier for university-originated technology. The two programs share the same phase structure and non-dilutive funding model but differ on two structural points:
- Research-institution partnership: optional under SBIR, mandatory under STTR — an STTR award requires a formal cooperative research agreement between the small business and a partnering U.S. nonprofit research institution (typically a university), with the business performing at least 40% of the work and the research institution at least 30%.
- PI employment: under STTR, the PI may be employed by either the small business or the partnering research institution — allowing a full-time faculty member to serve as PI while remaining on the university payroll, which is not possible under standard SBIR rules.
Five of the eleven SBIR agencies (currently DoD, HHS/NIH, DOE, NASA, and NSF) also run STTR programs. In both programs, agencies set aside a statutory minimum share of extramural R&D obligations: 3.2% for SBIR and 0.45% for STTR of each participating agency’s qualifying extramural R&D budget.
Why SBIR matters for university technology transfer
SBIR (and STTR) sits directly on the path most research administrators and technology transfer offices call the “valley of death” — the funding gap between a university invention disclosure and a level of technical/commercial maturity that private investors or licensees will fund. For a TTO, an SBIR or STTR award to a faculty-founded spinout typically depends on groundwork the office has already done or needs to do concurrently:
- An invention disclosure and, where the office has elected to retain title under the Bayh-Dole Act, a filed patent application establishing the IP position the SBIR proposal will build on.
- An exclusive license or option agreement from the university to the spinout for the foundational patent — many agencies’ SBIR reviewers explicitly weigh whether the applicant has a defined, secured path to the underlying IP, not just an inventor’s informal involvement.
- A conflict-of-interest review covering the faculty inventor’s dual role as university employee and startup founder/equity holder/consultant, since SBIR’s PI-employment rule interacts directly with how much time and in what capacity the inventor can spend on the company.
- Institutional policy on how SBIR/STTR indirect costs, cost-sharing, and any royalty or equity the university holds in the spinout are handled — these vary by institution and are typically set by the sponsored-programs and technology-transfer offices jointly.
Successful Phase I/II SBIR or STTR performance is also a common signal TTOs and licensees use when negotiating Phase III commercialization terms, since it demonstrates non-dilutive, peer-reviewed validation of the technology’s development milestones.
Program status: reauthorization and set-asides (2026)
SBIR and STTR’s statutory authority lapsed on September 30, 2025 after Congress did not act before the prior authorization expired, pausing new SBIR/STTR solicitations at several agencies. Congress passed a five-year reauthorization, the Small Business Innovation and Economic Security Act (S. 3971), which the Senate approved March 3, 2026 and the House approved March 17, 2026 (345–41); it extends SBIR and STTR authority through September 30, 2031. The reauthorization also introduced program changes, including a new higher-value “Strategic Breakthrough” Phase II award category at agencies with large SBIR budgets, mandatory award-decision timelines, and expanded national-security review of applicants. Because SBIR/STTR authority has lapsed and been extended by Congress before, research administrators should verify current solicitation status directly with sbir.gov or the specific funding agency rather than assuming year-round continuous availability.
Frequently asked questions
Can a university receive an SBIR award directly?
No. The small business is always the prime awardee; a university may only participate as a subcontractor performing a portion of the funded work.
Is SBIR funding dilutive to a startup’s equity?
No. SBIR awards are grants, cooperative agreements, or contracts — the federal government takes no equity or ownership stake and does not claim the intellectual property the award produces.
Does an SBIR award replace the need for a license from the university?
No. SBIR funds the R&D; it does not itself transfer any rights to a university-owned foundational patent. A spinout still needs a separate license or option agreement from the institution’s technology transfer office.
What’s the difference between SBIR Phase III and “commercialization funding”?
Phase III is not a distinct pool of SBIR money — it is a label for any non-SBIR-funded follow-on work (private investment, a non-SBIR federal contract, licensing revenue) that builds on a completed Phase I or II project.
References
- SBA/sbir.gov, program basics and eligibility tutorials — sbir.gov
- 15 U.S.C. § 638 (Small Business Innovation Research and Small Business Technology Transfer programs, as amended by the Small Business Innovation and Economic Security Act, S. 3971, enacted 2026)
- Small Business Innovation Development Act of 1982, Public Law 97-219
- Small Business Technology Transfer Act of 1992
- Congressional Research Service, “Small Business Research Programs: SBIR and STTR” (congress.gov)
Related terms and guides
- Technology Transfer & Innovation — cluster hub
- NSF I-Corps Program — the customer-discovery program many SBIR/STTR applicants complete before or alongside an award
- 35 U.S.C. § 102: Patent Novelty and Invention Disclosure Timing — why invention-disclosure timing matters before an SBIR proposal builds on university IP
- Conflict of Interest Disclosure Form — relevant when a faculty PI also holds equity in the SBIR/STTR awardee
- Grant vs. Contract vs. Cooperative Agreement — the funding-instrument types SBIR awards actually use
Also known as
Small Business Innovation Research · America's Seed Fund
Machine-readable encodings
Use in your systems
<role vocab="credit"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="SBIR (Small Business Innovation Research)"
vocab-term-identifier="https://casrai.org/dictionary/term/sbir" />{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/sbir",
"name": "SBIR (Small Business Innovation Research)",
"identifier": "https://casrai.org/dictionary/term/sbir",
"description": "A U.S. federal program, established by the Small Business Innovation Development Act of 1982, that reserves a statutory share of participating agencies' extramural R&D budgets for phased, non-dilutive (no equity, no government IP claim) Phase I/II awards to small, for-profit businesses developing technology with both federal-mission relevance and commercial potential; the awardee of record must always be the small business itself, never a university.",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/funding-finance#set",
"url": "https://casrai.org/dictionary/term/sbir",
"sameAs": [
"Small Business Innovation Research",
"America's Seed Fund"
],
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"dateModified": "2026-07-17T01:35:00",
"inLanguage": "en"
}
